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avid Botstein’s name came up
twice when the PLoS Genetics
editors tossed around ideas
for potential interviewees, and with
good reason. First, he is now director of
an exciting development on the
Princeton University campus, the
Lewis-Sigler Institute for Integrative
Genomics, which weaves the physical,
computational, and biological sciences
into a cohesive endeavor. Second, his
scientiﬁc discoveries have run the
gamut of organisms, from phage P22 to
yeast to humans. And third, David is no
shrinking violet; he has a deeply held
opinion about everything, and he isn’t
afraid to voice it.
For those of you who are familiar
with David, these words will likely ﬂy
off the page. There is little need to ply
him with pre-formed questions; once
you get him going, he is a verbal
tsunami. His zeal is legendary, and his
delight in people and ideas is palpable.
I met David at his ofﬁce in the Carl
Icahn Laboratory on a chilly February
morning after the snow had melted.
The building is the elegant design of
Rafael Vinoly. Its airy entranceway,
which spans the length of the curved
glass fac ¸ade, embraces a small cafe ´, a
cylindrical seminar hall, and, jarringly,
the 30-year-old lead-clad prototype of a
Frank Gehry house, which David aptly
refers to as the ‘‘armadillo.’’ Double-
helical shadows are cast by latticed
aluminum pillars that hug the portico’s
arc, and altogether too stylish, white,
Tom Vac and Pierre Paulin ‘‘Orange
Slice’’ chairs populate the space. Yet
tucked into a corner were six dowdy
Revcos and an ice-o-matic, signaling
that this building is not just a pretty
face.
I powered up my fancy new digital
Marantz recorder, stoked with a high-
capacity ﬂash card, and pushed the
record button. Here follow excerpts
from what proved to be the ﬁrst in a
double-header interview.
Jane Gitschier: Let’s start with the
Lewis-Sigler Institute. What are you
trying to do here?
David Botstein: Actually, I came here
to do something about science
education, an experiment, if you like.
As you know, I was at MIT
[Massachusetts Institute of Technology]
for many years and taught
undergraduate and graduate courses,
and was director of the graduate
program. Beth Jones and I invented the
whole project lab system. We were
instructors at that time [1969], a non-
tenure track appointment. You worked
in somebody’s lab, but you did
teaching.
JG: Whose lab were you in?
DB: I was with Maury Fox. Beth brought
yeast to Boris’s [Magasanik] lab. I
brought P22 to Fox’s lab. We weren’t
randomly chosen to do this. I think the
idea was that they brought people who
were particularly good
experimentalists to teach these lab
courses.
We were given this really awful
course to teach, and we made a
proposal to teach it in a better way,
which involved major changes in the
curriculum, and they [the older faculty]
went along with it. And in fact, I got a
job [as Assistant Professor] out of it.
There is something about teaching
that makes you a better researcher. I
know this is very countercultural
wisdom, but I believed it all along.
Luria, Magasanik, and Levinthal all
believed it. Levinthal and Luria both
had a very strong inﬂuence on me in
this regard.
That’s one part of the story!
The other part of the story is that
through the Academy [National
Academy of Sciences], I became very
interested in the question of why it is
that there are fewer and fewer kids in
America who are interested in biology.
And through the Academy studies, it
became clear from the statistics that
the total number of kids interested in
any kind of science had been falling for
the last 30 years. And the conventional
wisdom is that it is all about K–12
education.
I don’t believe that for a second.
JG: And why is that?
DB: I’ll tell you the argument. There are
three arguments why this is not right.
One is that it is a mistake to think
that the high schools were ever so good.
There is zero argument to say that they
have gotten any worse. If you ask about
the absolute number of kids who get
calculus in high school, it has risen 10-
or 20-fold in the last 30 years. When I
went to college in the late 50s, I actually
did have advanced placement, but it
was rare!
Second argument is that if you look
at the outcomes of kids who get degrees
in science and then go to graduate
school—this is actually a Tom Cech
study published in the Daedalus just
before he became head of the
Hughes—and you ask where the
graduate students come from, it turns
out that small colleges, like
Swarthmore, who draw from exactly
the same pool as the big universities
like Princeton, Harvard, and Stanford,
are many-fold better at motivating
students to become professional
scientists. It’s something like 5-fold.
Third argument is that who was
teaching whom in the 50s and 60s was
very different [than now]. I had
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was Konrad Bloch before he got the
Nobel Prize. He had nothing better to
do than teach 120 kids biochemistry.
He did it very well. He took it very
seriously. He did not go to the dean
and say, ‘‘Oh, I have this grant and I’m
about to win a Nobel Prize and
therefore I should be free to do
research.’’
He understood, as I think we all
understood, that there is an organic
connection between teaching and
research. So I came with all this
baggage. And Ira Herskowitz, and
basically the MIT school, had that
baggage. You remember what it was
like! Luria taught 7.01 [introductory
biology]; Boris taught microbiology.
Gene Brown had 7.05 [biochemistry].
The leaders were leading from the
front!
For various reasons, there were issues
at Stanford, and I was motivated at
least to look at my alternatives. I had
been talking on and off with Shirley
[Tilghman], because this institute was
started and Shirley was going to be the
director, and then they made her
president [of Princeton]. And she had
incorporated the idea, which I think
was really very smart, that there was
already at Princeton an unusually close
relationship between the molecular
biologists and the physicists.
There came a moment when I called
Shirley and said I had ideas about what
could been done with such a place. It
was a substantial departure from what
she had intended. I submitted myself to
the formal process and tried to
convince everybody to do what we’re
doing—which was to say, ‘‘Let’s see if
we can do something for a subset of
students who, I believe, are
underserved in the university.’’
Students who are not going to medical
school, necessarily, but who are actually
interested in physics or chemistry or
molecular biology—who in high school
hadn’t advanced so far that they
already differentiated into physicists or
chemists or biologists.
What happens to students who come
to college wanting to learn
biochemistry? They ﬁnd themselves
ﬁrst in a chemistry class with a hundred
students with absolutely no interest in
chemistry. All of those students drill a
hole in the head of the instructors and
each other to get the best possible
grade because all they want is the
grade. You teach these people later,
and you realize that they are
unteachable, to a ﬁrst approximation. I
have never failed as a teacher, except
when trying to teach genetics to
medical students.
I knew that reform was impossible.
The word reform never passes my lips.
Instead, what I proposed was that we
use this building, which could house as
many as 15 or 16 new faculty, and use
resources in the various ﬁelds to mount
an alternative introductory curriculum
in the ﬁrst two years—at a very high
level for students who are willing to do
the math, students who want to learn
computation—and offer incoming
freshmen a choice. Students could
learn in the usual way, with the
standard, well-worked out curriculum.
Math—you can go back 200 years, and
you can’t ﬁnd a new thought.
Chemistry is taught in exactly the same
way that Linus Pauling prescribed in
his book published, I think, in 1926.
Or the students could participate in
this new experiment in which we’ll
teach computer science, physics,
chemistry, and molecular biology
corresponding to the introductory
level in six semesters of work—four in
the ﬁrst year, two in the second year—
and then major in any of those areas.
What we did was we had eight senior
faculty, a sort of Noah’s ark of science,
sit every Monday at lunch for two to
three hours and simply ask the
following question for all of these ﬁelds
at the most introductory level: Is this
problem or this idea or this concept
fundamental, or merely traditional? We
collected all the fundamentals and did
the best we could to make them into a
coherent sequence.
We tell the students, ‘‘This is not the
low-energy path to medical school.’’
When they come here, they have fear
and trepidation, but I tell them,
privately anyway, ‘‘Look, ifyou don’t get
too many Cs and you work in
somebody’s lab and do a good job, you’ll
get into any graduate school in the
country. So stop worrying about the
grades. If you get a B in everything that
we do, you’ll be a heroine or a hero.’’
The adventurous students, the risk
takers, come to us. They know how
deadening it is to be part of premedical
or preprofessional education. It is a
mistake to underestimate the
perceptiveness ofchildren, asyou know!
The breadth of the program has
really been its great strength. Morale is
very high. The other day, one of our
students came to me and said she was
thinking of majoring in computer
science. She said, ‘‘I knew nothing, and
I was terriﬁed of it, and I had no idea. If
DOI: 10.1371/journal.pgen.0020079.g001
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have learned to program, but I love it!’’
Well, that’s what we’re here for!
The students had a ﬁnal exam last
spring, worth half their entire grade for
the year, and all of them showed up in
identical T-shirts they had designed.
These students are really terriﬁc. I
haven’t seen students like this since 20,
25 years ago at MIT. They are really
turned on.
We have an endowment for ﬁve
Lewis-Sigler Fellows. We search the
country for the best experimentalists
we can ﬁnd, right out of graduate
school, no post-doc. And we say,
‘‘Instead of being a post-doc, we’ll give
four benches, $250K a year for
research, and you can stay for ﬁve
years—but you have to teach the lab
part of the undergraduate curriculum.’’
And they are fantastic.
JG: Sounds like you’ve recreated your
old job at MIT! What about the
graduate program?
DB: The graduate school is a more
difﬁcult problem, and it’s a problem we
haven’t solved—yet—but we’re working
on it. We started this Quantitative and
Computational Biology Program. This
is being led by Leonid Kruglyak, who
graduated from Princeton summa cum
laude in physics. So the idea is that we
are going to do exactly the same thing
that we did with the undergraduates, in
a way. All the participating
departments, of which there are many,
are going to admit a bunch of students
who might be interested in the other
ﬁeld, and we’ll try to teach them a few
things together.
We have one such course called
Method and Logic in Quantitative
Biology, and we teach the classic
papers, many of which are forgotten
because they can’t be taught now
because people don’t understand the
math. You may remember reading
Luria and Delbruck, and you may
remember that nobody understood
Luria and Delbruck because they didn’t
have the math—and these were MIT
graduate students! Poisson
distribution—don’t bother me.
JG: The teaching enterprise is the big
glue that is holding this institute
together.
DB: And that’s part of why they hired
me, because they understood that
eating lunch together was probably not
going to be good enough to actually get
people to talk to each other seriously.
People need to have some common
task that is orthogonal to their own
research, and eventually, before you
can turn around, they are doing stuff
together.
This endeavor is not a solo endeavor
of mine. Bill Bialek in physics and in
the Lewis-Sigler Institute is the
architect of the syllabus itself, and the
main lecturer in the ﬁrst semester. The
laboratory parts of the freshman course
were designed and run by two fellows—
Maitreya Dunham, a geneticist, and
Will Ryu, a physicist. These fellows are
terriﬁc. I’m organizing everything so
that by the time I retire in seven years,
everything will run on younger people,
and they won’t actually need me. I’m no
spring chicken!
JG: Let’s talk a bit about your roots.
Your younger brother Leon is a well-
known conductor, and I read
somewhere that you also considered a
career in music.
DB: Brieﬂy. When I was in college, I did
take harmony and counterpoint and
was in the music scene. I was doing that
and physics. But physics was taking
most of my time.
What I was interested in was choral
conducting. I was a singer. I sang in the
Harvard glee club, and I was the
rehearsal conductor sometimes. I still
remember trying to get people to get
the rhythm right in Stravinsky’s Oedipus
Rex. It’s not that hard, but it’s amateur
singers. I don’t have such a great voice,
but I knew about music.
JG: Are you a baritone?
DB: Yes. In those days I could do bass; I
had an acceptable F and an audible E,
so it was enough. I was pretty good in
the midrange. The high notes were not
too challenging for me. I sang for many,
many years. I sang, memorably, when
Kennedy was killed. A huge pick-up
group sang the Mozart Requiem in
Symphony Hall. That was really an
occasion.
JG: Did your parents sing?
DB: My mother’s family was heavily into
music in the old country in Poland. My
grandfather was a great patron of the
arts; he was a very rich man. There were
many famous musicians who he
sponsored to go to conservatory from
that area of Poland. He survived the
Holocaust, and I knew him.
My mother was a pediatrician. She
was [Guido] Fanconi’s assistant. She was
in fact the ﬁrst to show that cystic
ﬁbrosis is inherited.
JG: How did she show that?
DB: A family study in Switzerland
during the war. Dorothy Anderson did
the same thing at Columbia Babies
Hospital, and our literature was all
Anderson [because Fanconi published
only in German]. It was Fanconi, of
course, who discovered cystic ﬁbrosis.
JG: I didn’t know that.
DB: Failure to thrive, just like Fanconi’s
anemia.
Both my parents were physicians. My
father was what you would call today a
radiation oncologist. He was the ﬁrst in
this country to use betatrons.
JG: Was your father Swiss?
DB: Neither was Swiss. They were there
in medical school [in Zurich], and they
stayed there as residents and then the
war broke out. He was from Poland
also. Actually, the family comes from
Odessa. The other side comes from
Vilnius.
My mother was Fanconi’s oberartz—
the chief resident. Ania Wyszewianska,
later Anne Botstein. When she came to
this country, she was offered positions
in various places, but she started to lose
her hearing—she had Meniere’s
disease. She went into private practice.
She worked in one of the ﬁrst HMO’s in
New York, a place called the HIP at
Monteﬁore hospital where she was
Chief of Pediatrics for 25 years, so she
was very successful. My father went
academic and was a professor at
Einstein. And he is very well known. His
residents are all over the country.
JG: So you lived where?
DB: In the Bronx, in Riverdale, on the
corner of the Hudson River, and on the
Yonkers border.
JG: You were born in Switzerland?
DB: Yes.
JG: Did you have Swiss citizenship?
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citizenship for foreigner Jews. Swiss
citizenship is hereditary.
We were stateless, and then my
parents got a visa for the United States
in 1949. They had applied for an
American visa in 1935 when they were
married, but the Polish quota was full.
Fourteen years later, one of their
friends was at the US consulate, and
they had just posted a list on the door
of who had a visa, and they noticed that
my parents were on the list. My parents
had two weeks’ notice to make up their
minds as to whether they would come.
And they did.
I remember that trip very well. I was
seven. My mother had a cousin in New
York, and they had letters of
recommendation from their bosses in
Switzerland who were very well known.
My mother tells the story of taking the
boards in pediatrics, and it was all
‘‘anonymous.’’ She had Nelson, of the
famous textbook in Pediatrics, as her
examiner, and they talked about polio
and this and that, and then he says,
‘‘Well, you really know these statistics
very well. I’m not supposed to do this,
but I know you are not Fanconi—you
must be Botstein!’’ And then they
gossiped the rest of the time. It’s the
same thing as if Sydney Brenner tried
to interview Ira Herskowitz.
My mother is still alive, and she lives
in an apartment right next to my
brother, and I see them nearly every
week now. My brother and I have
always been very close. He’s the famous
one. And deservedly so. He’s a real
innovator in teaching, too!
JG: Since I’m a human geneticist, I can’t
help but ask you about the genesis of
the 1980 mapping paper with Davis and
colleagues [in American Journal of Human
Genetics].
DB: That’s famously been written up a
number of times. The account in
Bishop and Waldholtz’s book Genome is
actually very accurate, as I recall.
JG: I want to hear it in your words.
DB: I was teaching with [Ron] Davis and
[John] Roth, at Cold Spring Harbor, the
bacterial genetics course in 1978. Jim
[Watson], typically, was too cheap to
allow us to get together. Roth was in
Utah, I was in Boston, and Davis was at
Stanford. So Roth ﬁnagled that we,
Davis and I, would be outside readers
for the training grant that Utah had.
The genetics training program had a
retreat in Alta.
We had to listen to all the talks, and
one of the talks was by one of [Mark]
Skolnick’s students, the guy who did
hemochromatosis, what’s his name? If
you’re gonna make history you gotta
look all this up. [Meanwhile, David does
a quick PubMed search.] This kid got
up and talked about how there were
two ways to think about
hemochromatosis and one of them
involved linkage to HLA [human
leukocyte antigen]. And the linkage to
HLA would make hemochromatosis
recessive. And you could build a
reasonable model, and they had a
likelihood score for that possibility.
Kerry Kravitz! 1978!
There were, at Utah, a lot of hard
heads, mainly immunologists, and these
immunologists said, ‘‘This is bull; it’s
got to be physiological because HLA
affects all this other stuff, and you guys
are talking through your hats.’’ They
didn’t like Skolnick’s approach. They
didn’t like the whole idea.
Now, of course, it’s 1978, nobody
knows what a LOD [logarithm of the
odds] score is, and the only person in
the room who knows, besides Skolnick
and Kravitz, is Botstein. So I ﬁnd myself
in the middle of this argument. This
argument erupts, and I am defending
this student because the student and I
understand what he did, and nobody
else does, and he has not managed to
explain it. Skolnick isn’t explaining it
either. None of these guys are great
explainers. It’s a medical school, okay!
So ﬁnally I say something like, ‘‘Look
there is nothing special about HLA.
What’s good about HLA is that it has
many alleles, and because it has many
alleles, you can tell if you have linkage,
and if you have many multiallelic
markers all over the genome, you can
map anything!’’ And as soon as the
words were out of my mouth, I look at
Davis, Davis looks at me, and we both
understand that of course there are
such markers, and we could make a
map of the human genome tomorrow.
JG: What kind of markers were you
thinking of?
DB: We were thinking of two things,
one of which would now be called SNPs
[single nucleotide polymorphisms] and
the other, which we expected would be
more common, was insertion
sequences, movements of
transposons—because in yeast, that was
what was going on. You see, Davis’s part
of this was TY1. Remember what my
history is. In 1978, what was I known
for?
JG: Uh, I give up.
DB: Tn10! We were one of the groups
that discovered transposons in
bacteria. Russell Chan, Nancy
Kleckner—making mutations,
mobilizing genes. It was a really big
deal. So the ﬁrst thing we thought of
was, ‘‘Oh, there are going to be
transposons all over the place!’’
We were surprised to discover that
the really good markers were all these
CA repeats. We did not anticipate that.
But I understood pretty much the
whole thing, and then the rest of that
meeting was—we sat in the bar, we
drank, and we ﬁgured out how we
could make a map of the human
genome: how it would work and how
many markers we would need. The
whole 1980 paper. Everything in there
was there in outline by the end of the
day.
I went home and I explained it all to
Maury Fox, and he understood why this
was interesting, and he understood the
math. And I persuaded Ray White to
look for polymorphisms because he had
been doing this transposon jumping
around business in introns and
ribosomal DNA in Drosophila. And it
wasn’t going anywhere. He had the
right technology. And then he and
Arlene Wyman found what is now
called D14S1, and we were off.
What was really noticeable at the
time was that the human geneticists
didn’t get it. At all. At all, at all, at all. It
took a really long time. Skolnick was
beating the drum. In 1983, I went to the
ASHG [American Society of Human
Genetics] meeting, and I gave this long
discussion of how it all would work, and
I had to explain Southern blot and this
and that. I went to NIH [National
Institutes of Health] and tried to get
money, and Ruth Kirschstein looked at
me and said, ‘‘We don’t do things like
that.’’ That was the origin of her
opposition to the genome project, I’m
sure.
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[mapped Huntington disease]. On the
one hand, it gave the idea some
credibility; on the other, it did
everybody a huge disservice, because
people started to look with random
markers. And the statistics!
JG: They were so lucky; it was the
twelfth marker!
DB: The eighth! The eighth! The prior
probability of ﬁnding it in eight
markers was zero! I knew that!
JG: Well, for once, ignoring the math
paid off! “
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